View of MONITORING ADVERSE EVENTS ASSOCIATED WITH DAPAGLIFLOZIN TREATMENT IN TYPE 2 DIABETES PATIENTS: A POST-MARKETING SURVEILANCE PROGRAM IN VIETNAM

Return to Article Details MONITORING ADVERSE EVENTS ASSOCIATED WITH DAPAGLIFLOZIN TREATMENT IN TYPE 2 DIABETES PATIENTS: A POST-MARKETING SURVEILANCE PROGRAM IN VIETNAM Download Download PDF